AltPep
About:
AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Website: https://www.altpep.com
Top Investors: Eli Lilly, Alexandria Venture Investments, Partners Investment, Section 32, Senator Investment Group
Description:
AltPep Corp is a biomedical startup with a breakthrough approach for diagnosing and treating some of the world’s most intractable diseases: amyloid diseases.
Total Funding Amount:
$76.1M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Seattle, Washington, United States
Founded Date:
2018-01-01
Contact Email:
info(AT)AltPep.com
Founders:
Michael Mullan, Valerie Daggett
Number of Employees:
11-50
Last Funding Date:
2023-06-22
IPO Status:
Private
Industries:
© 2025 bioDAO.ai